Monday, July 20, 2026
🇺🇸 FDA

Intelligence · Patents

Recently granted patents

New US pharmaceutical patent grants from the past 12 months — competitive surveillance for BD and IP teams.

Patents
38

Quick answer

38 pharmaceutical patents in our USPTO index were granted within the past year. Browse by grant date with links to applicant company portfolios and related drug profiles.

  1. WO 2026109729

    COMBINAISON COMPRENANT LE CAPIVASERTIB ET L'ABIRATÉRONE POUR LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE SENSIBLE AUX HORMONES (MHSPC) DÉFICIENT EN PTEN

    ASTRAZENECA AB [SE] · Granted 2026-05-28T00:00:00.000Z · Expires 2046-05-23T00:00:00.000Z

    granted

  2. WO 2026078615

    ASSOCIATION DE TALAZOPARIB ET D'ENZALUTAMIDE DANS LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE RÉSISTANT À LA CASTRATION

    PFIZER [US] · Granted 2026-04-16T00:00:00.000Z · Expires 2046-04-11T00:00:00.000Z

    granted

  3. WO 2026078619

    ASSOCIATION DE TALAZOPARIB ET D'ENZALUTAMIDE DANS LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE RÉSISTANT À LA CASTRATION

    PFIZER [US] · Granted 2026-04-16T00:00:00.000Z · Expires 2046-04-11T00:00:00.000Z

    granted

  4. US 20260097057

    COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS

    ASTRAZENECA AB [SE] · Granted 2026-04-09T00:00:00.000Z · Expires 2046-04-04T00:00:00.000Z

    granted

  5. WO 2026027669

    BIOMARQUEURS POUR DÉTERMINER LE TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AVEC DU FILGOTINIB

    ALFASIGMA SPA [IT] · Granted 2026-02-05T00:00:00.000Z · Expires 2046-01-31T00:00:00.000Z

    granted

  6. US 20260027049

    AVACOPAN FORMULATIONS

    AMGEN INC [US] · Granted 2026-01-29T00:00:00.000Z · Expires 2046-01-24T00:00:00.000Z

    granted

  7. US 12533358

    Methods of treatment with elinzanetant

    BAYER CONSUMER CARE AG [CH] · Granted 2026-01-27T00:00:00.000Z · Expires 2046-01-22T00:00:00.000Z

    granted

  8. EP 4681704

    NEUE FORMULIERUNGEN VON PITOLISANT

    BIOPROJET PHARMA [FR] · Granted 2026-01-21T00:00:00.000Z · Expires 2046-01-16T00:00:00.000Z

    granted

  9. WO 2026013310

    COMPOSITION PHARMACEUTIQUE LIQUIDE À BASE DE STIRIPENTOL

    BIOCODEX [FR] · Granted 2026-01-15T00:00:00.000Z · Expires 2046-01-10T00:00:00.000Z

    granted

  10. WO 2025221754

    UPADACITINIB DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE L'ARTÉRITE À CELLULES GÉANTES

    ABBVIE INC [US] · Granted 2025-10-23T00:00:00.000Z · Expires 2045-10-18T00:00:00.000Z

    granted

  11. US 2025295738

    Long-Acting Growth Hormone Dosage Forms With Superior Efficacy to Daily Somatropin

    ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S [DK] · Granted 2025-09-25T00:00:00.000Z · Expires 2045-09-20T00:00:00.000Z

    granted

  12. US 12419895

    Methods for treating subjects with Prader-Willi syndrome

    ESSENTIALIS, INC. · Granted 2025-09-23T00:00:00.000Z · Expires 2045-09-18T00:00:00.000Z

    granted

  13. US 12414942

    Compositions, methods, and systems for treating presbyopia

    LENZ THERAPEUTICS OPERATIONS, INC. · Granted 2025-09-16T00:00:00.000Z · Expires 2045-09-11T00:00:00.000Z

    granted

  14. US 12410184

    Crystalline forms of a menin inhibitor

    Kura Oncology, Inc. · Granted 2025-09-09T00:00:00.000Z · Expires 2045-09-04T00:00:00.000Z

    granted

  15. US 12403090

    Oral film compositions and dosage forms having precise active dissolution profiles

    Aquestive Therapeutics, Inc. · Granted 2025-09-02T00:00:00.000Z · Expires 2045-08-28T00:00:00.000Z

    granted

  16. US 12404227

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted 2025-09-02T00:00:00.000Z · Expires 2045-08-28T00:00:00.000Z

    granted

  17. US 12396963

    Cannabidiol-type cannabinoid compound

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted 2025-08-26T00:00:00.000Z · Expires 2045-08-21T00:00:00.000Z

    granted

  18. US 12398087

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted 2025-08-26T00:00:00.000Z · Expires 2045-08-21T00:00:00.000Z

    granted

  19. US 12390419

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    AXSOME MALTA LTD. · Granted 2025-08-19T00:00:00.000Z · Expires 2045-08-14T00:00:00.000Z

    granted

  20. US 12390453

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted 2025-08-19T00:00:00.000Z · Expires 2045-08-14T00:00:00.000Z

    granted

  21. US 12383535

    Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor

    CHINA PHARMACEUTICAL UNIVERSITY · Granted 2025-08-12T00:00:00.000Z · Expires 2045-08-07T00:00:00.000Z

    granted

  22. US 12383512

    Cannabidiol-type cannabinoid compound

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted 2025-08-12T00:00:00.000Z · Expires 2045-08-07T00:00:00.000Z

    granted

  23. US 12383516

    Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

    Amphastar Pharmaceuticals, Inc. · Granted 2025-08-12T00:00:00.000Z · Expires 2045-08-07T00:00:00.000Z

    granted

  24. US 12383545

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted 2025-08-12T00:00:00.000Z · Expires 2045-08-07T00:00:00.000Z

    granted

  25. US 12384743

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    AXSOME MALTA LTD. · Granted 2025-08-12T00:00:00.000Z · Expires 2045-08-07T00:00:00.000Z

    granted

  26. US 12383503

    Adagrasib solid pharmaceutical compositions

    Mirati Therapeutics, Inc. · Granted 2025-08-12T00:00:00.000Z · Expires 2045-08-07T00:00:00.000Z

    granted

  27. US 12377104

    Methods for treating a fatty liver disease

    Madrigal Pharmaceuticals, Inc. · Granted 2025-08-05T00:00:00.000Z · Expires 2045-07-31T00:00:00.000Z

    granted

  28. US 12377096

    Methods of treating disease with levoketoconazole

    XERIS PHARMACEUTICALS, INC. · Granted 2025-08-05T00:00:00.000Z · Expires 2045-07-31T00:00:00.000Z

    granted

  29. US 12370241

    Nasal powder formulation for treatment of hypoglycemia

    Amphastar Pharmaceuticals, Inc. · Granted 2025-07-29T00:00:00.000Z · Expires 2045-07-24T00:00:00.000Z

    granted

  30. US 12370163

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Granted 2025-07-29T00:00:00.000Z · Expires 2045-07-24T00:00:00.000Z

    granted

  31. US 12371420

    Polymorphs of Selinexor

    Karyopharm Therapeutics Inc. · Granted 2025-07-29T00:00:00.000Z · Expires 2045-07-24T00:00:00.000Z

    granted

  32. US 12370196

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted 2025-07-29T00:00:00.000Z · Expires 2045-07-24T00:00:00.000Z

    granted

  33. US 12370142

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted 2025-07-29T00:00:00.000Z · Expires 2045-07-24T00:00:00.000Z

    granted

  34. US 12364671

    Methods of administering vitamin A and lactic acid to gilts

    China Agricultural University · Granted 2025-07-22T00:00:00.000Z · Expires 2045-07-17T00:00:00.000Z

    granted

  35. US 12364670

    Cannabidiol-type cannabinoid compound

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted 2025-07-22T00:00:00.000Z · Expires 2045-07-17T00:00:00.000Z

    granted

  36. US 12365899

    RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

    Arrowhead Pharmaceuticals, Inc. · Granted 2025-07-22T00:00:00.000Z · Expires 2045-07-17T00:00:00.000Z

    granted

  37. US 12364685

    Isoxazoline parasiticide formulations

    Tarsus Pharmaceuticals, Inc. · Granted 2025-07-22T00:00:00.000Z · Expires 2045-07-17T00:00:00.000Z

    granted

  38. US 12364683

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted 2025-07-22T00:00:00.000Z · Expires 2045-07-17T00:00:00.000Z

    granted

Frequently asked questions

How recent are these patent grants?

This hub lists published patents with a grant date within the last 365 days, ordered newest first.

Which patent classes are included?

We index USPTO PatentsView records with pharmaceutical CPC classifications A61K and A61P linked to tracked assignee companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.